Updated time: 2021-03-03 15:27:33
09A-1040703
TW I717547、PCT patent pending
The invention provides methods to differentiate DNA of one type from a mix of DNA by their epigenetic signatures, followed by statistical algorithm to accurately determine if there exists abnormal copy number of chromosomes within a mixture of DNA.
- Enable an earlier detection with non-invasive prenatal testing during early pregnancy with a lower risk (earlier than the current standard: 10 weeks)
- Largely increase the accuracy of non-invasive prenatal testing (143% of the current testing accuracy)
The invention is particularly useful in detecting genetic genomic variations and abnormality including non-invasive prenatal test (NIPT) to detect Down syndrome and other aneuploidies, gender typing, cancer research for cancerous cells detection.

refers to a schematic plot of the methods (Methods 1 to 5) of the invention. Method 1 enriches methylated DNA of specific target sites, Method 2 enriches methylated DNA and performs genome-wide screening, Method 3 differentiates DNAs by their methylation patterns based on the location of the MSRE cutting site relative to the 5′ end of reads, and Method 4 segregates genome-wide methylation profiles to infer genomic copy number variation of DNA of different types.
Pao-Yang Chen, Ming-Ren Yen, Fei-Man Hsu, Yi-Jing Lee
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Epigenetic Discrimination of DNA